Contrasting Phreesia (PHR) & Its Rivals

Phreesia (NYSE:PHR) is one of 93 public companies in the “Healthcare Technology” industry, but how does it compare to its peers? We will compare Phreesia to related companies based on the strength of its profitability, valuation, analyst recommendations, dividends, earnings, institutional ownership and risk.

Volatility and Risk

Phreesia has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, Phreesia’s peers have a beta of 1.06, meaning that their average stock price is 6% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and price targets for Phreesia and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1	10	8	0	2.37
Phreesia Competitors	446	1513	2723	88	2.51

Phreesia presently has a consensus target price of $14.07, indicating a potential upside of 13.70%. As a group, “Healthcare Technology” companies have a potential upside of 37.31%. Given Phreesia’s peers stronger consensus rating and higher probable upside, analysts plainly believe Phreesia has less favorable growth aspects than its peers.

Insider & Institutional Ownership

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 42.3% of shares of all “Healthcare Technology” companies are owned by institutional investors. 5.2% of Phreesia shares are owned by insiders. Comparatively, 16.0% of shares of all “Healthcare Technology” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Phreesia and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Phreesia	2.06%	5.22%	3.02%
Phreesia Competitors	-778.94%	-34.14%	-15.64%

Valuation and Earnings

This table compares Phreesia and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Phreesia	$480.59 million	$2.31 million	72.78
Phreesia Competitors	$355.95 million	-$24.15 million	13.19

Phreesia has higher revenue and earnings than its peers. Phreesia is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Phreesia beats its peers on 7 of the 13 factors compared.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.